Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Researchers at University of Colorado have published new data on breast cancer
May 12th, 2008
"Microtubules are formed by an equal amount of alpha- and beta-tubulins through a dynamic process of polymerization and depolymerization that reaches equilibrium. Tubulin-targeting agents affect the microtubule function to disrupt cell shape, microvesicle transportation, and spindle formation," scientists in the United States report. "The use of tubulin-targeting agents, especially the newer agents such as taxanes, has significantly increased the response and even survival in patients with many cancers, including breast cancer. However, not all patients respond to these agents. Also, most patients develop recurrent or progressive disease, especially in the metastatic...
Source: Biotech Business Week (2008-05-12)
|
